Skip to main content

Table 3 Biochemical changes following SWL (n = 12)

From: Shock wave lithotripsy, for the treatment of kidney stones, results in changes to routine blood tests and novel biomarkers: a prospective clinical pilot-study

 Baseline30 min120 min240 minReference rangep valueStatistical test
CRP (mg/L)3.1 (± 1.0/8.0)1.65 (± 1.0/7.0)1.8 (± 1.0/7.5)1.9 (± 1.0/6.40)0–5.00.101Friedman
Total protein (g/L)71.33 ± 4.8367.93 ± 4.23*64.45 ± 3.45*67.64 ± 3.03*60.0–80.0< 0.001ANOVA
Albumin (g/L)43.13 ± 3.040.90 ± 3.12*39.33 ± 3.5*40.77 ± 3.2235.0–45.0< 0.001ANOVA
Globulin (g/L)28 (± 25/37)28 (± 22/30)26 (± 23/27)*26.5 (± 25/30)23.0–35.00.006Friedman
Total bilirubin (µmol/L)13.5 (± 7/23)15 (± 7/22)12 (± 9/43)11 (± 8/22)< 210.140Friedman
Alkaline phosphatase—ALP (U/L)73 (± 36/91)65 (± 37/93)*68.5 (± 35/85)*72.5 (± 34/86)30.0–130.00.018Friedman
Alkaline transaminase—ALT (U/L)35.5 (± 18/70)34 (± 18/65)35 (± 17/62)37 (± 15/67)*< 41 (male)
< 33 (female)
0.01Friedman
Urea (mmol/L)4.90 (± 2.7/6.0)4.80 (± 2.8/6.0)4.90 (± 3.6/5.20)4.85 (± 3.30/5.20)2.5–7.80.478Friedman
Creatinine (µmol/L)67.1 (± 11.39)69.7 (± 13.04)73.0 (± 12.30)71.1(± 14.09)M: 58.0–110.0
F: 46.0–92.0
0.365ANOVA
Sodium (mmol/L)140 (± 135/140)139 (± 132/143)*137 (± 134/142)*138 (± 133/140)*135.0–146.00.010Friedman
Potassium (mmol/L)4.27 (± 3.9/4.6)4.37 (± 3.64/4.60)4.12(± 3.4/5.0)4.2 (± 3.8/4.60)3.5–5.30.291Friedman
  1. Statistical significance following post hoc analysis is represented when *p ≤ 0.05. (M, male; F, female)